EGFR and adenocarcinoma: The EGFR mutation rate of 7.8% in adenocarcinomas observed in our study was lower than what is typically reported in the international literature, where EGFR mutations range from 10 to 15% in Western populations and up to 40% in Asian cohorts [28,29,30].